Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images? | Zendy

Shintaro Ichikawa | Zendy; Tomoaki Ichikawa | Zendy; Utaroh Motosugi | Zendy; Katsuhiro Sano | Zendy; Hiroyuki Morisaka | Zendy; Nobuyuki Enomoto | Zendy; Masanori Matsuda | Zendy; Hideki Fujii | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?

Author(s) -

Shintaro Ichikawa,

Tomoaki Ichikawa,

Utaroh Motosugi,

Katsuhiro Sano,

Hiroyuki Morisaka,

Nobuyuki Enomoto,

Masanori Matsuda,

Hideki Fujii

Publication year - 2015

Publication title -

liver cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.916

H-Index - 34

eISSN - 2235-1795

pISSN - 1664-5553

DOI - 10.1159/000367736

Subject(s) - gadoxetic acid , hccs , magnetic resonance imaging , hepatocellular carcinoma , medicine , hepatocyte , hyperintensity , radiology , nuclear medicine , gadolinium dtpa , chemistry , biochemistry , in vitro

During the follow-up of patients with chronic liver disease, hypervascular hepatocellular carcinomas (HCCs) can develop either from pre-existing high-risk nodules or by de novo hepatocarcinogenesis. The purpose of this study was to evaluate, by retrospective analysis, the detectability and signal intensity on previous hepatocyte-phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) of hypervascular HCC initially detected on current EOB-MRIs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research